PLEASANTON, Calif. (AP) — PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Tuesday reported a loss of $35.8 million in its third quarter.

On a per-share basis, the Pleasanton, California-based company said it had a loss of 30 cents.

The results topped Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 34 cents per share.

The life science technology company posted revenue of $151.7 million in the period.

10x Genomics expects full-year revenue in the range of $595 million to $605 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TXG at https://www.zacks.com/ap/TXG